Advanced Enzyme Tech Quarterly Results for Trading Insights
ADVENZYMES • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹45 Cr
QSept 2025
Advanced Enzyme Tech Quarterly Results Key Highlights
- Revenue of ₹195 Cr in Sept 2025 (+10.8% vs Mar 2025, +25.0% vs Sept 2024)
- Net Profit of ₹45 Cr in Sept 2025 (+66.7% vs Mar 2025, +36.4% vs Sept 2024)
- EBITDA of ₹70 Cr in Sept 2025 (+29.6% vs Mar 2025)
- Operating Margin of 33.0% in Sept 2025 (+6.0pp vs Mar 2025)
- Earnings Per Share of ₹3.87 in Sept 2025 (+63.3% vs Mar 2025)
Advanced Enzyme Tech Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 195 | 176 | 195 | 192 | 156 | 10.8% | 25.0% |
| Net Profit (₹ Cr) | 45 | 27 | 40 | 43 | 33 | - | - |
| EBITDA (₹ Cr) | 70 | 54 | 65 | 69 | 52 | - | - |
| EPS (₹) | 3.87 | 2.37 | 3.57 | 3.80 | 2.94 | - | - |
| Operating Margin (%) | 33.0% | 27.0% | 30.0% | 29.0% | 29.0% | - | - |
Advanced Enzyme Tech Share Price Trend Around Quarterly Results
Visualize Advanced Enzyme Tech's 1-year price movement across quarterly results — ideal for logging trades in Advanced Enzyme Tech share price
chart using Tickjournal. All values in ₹.
Related Pages for Advanced Enzyme Tech
Additional stock information and data for ADVENZYMES
Revenue Trend (₹ Cr)
Dec 2025
192
Jun 2025
195
Mar 2025
176
Sept 2025
195
Net Profit Trend (₹ Cr)
Dec 2025
43
Jun 2025
40
Mar 2025
27
Sept 2025
45
Operating Margin Trend (%)
Dec 2025
29.0%
Jun 2025
30.0%
Mar 2025
27.0%
Sept 2025
33.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Advanced Enzyme Tech quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.5 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6352.5 | 2,860 | 689 | +7.1% | - | 24.1% | 244.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4431.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1325.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1329.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores